Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. (Q44016035)
Jump to navigation
Jump to search
scientific article published on 3 May 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression. |
scientific article published on 3 May 2012 |
Statements
Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression (English)
Matthias Oelze
Maike Knorr
Swenja Kröller-Schön
Anna Gottschlich
Robert Rümmler
Alexandra Schuff
Steffen Daub
Tommaso Gori
Andreas Daiber
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference